Progress regarding the context-of-use of tau as biomarker of Alzheimer’s disease and other neurodegenerative diseases

The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases

(2020) Filippo Baldacci et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis

(2020) Samir Abu-Rumeileh et al.   JOURNAL OF NEUROLOGY

Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

(2020) Shorena Janelidze et al.   NATURE MEDICINE

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

(2020) Elisabeth H. Thijssen et al.   NATURE MEDICINE

Novel ELISAs to measure total and phosphorylated tau in cerebrospinal fluid

(2020) Takeshi Kawarabayashi et al.   NEUROSCIENCE LETTERS

Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes

(2020) Alexander G Murley et al.   BRAIN

Aβ1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis

(2020) Débora Lanznaster et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The discriminative capacity of CSF β-amyloid 42 and Tau in neurodegenerative diseases in the Chinese population

(2020) Ling-Qi Ye et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

(2020) Thomas K Karikari et al.   LANCET NEUROLOGY

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease

(2020) Nicolas R. Barthélemy et al.   NATURE MEDICINE

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease

(2020) Shorena Janelidze et al.   Nature Communications

Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes

(2020) Adam S. Fleisher et al.   JAMA Neurology

A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease

(2020) Harald Hampel et al.   Frontiers in Immunology

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

(2020) Sebastian Palmqvist et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease

(2020) Nicolas R. Barthélemy et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy

(2020) Matthias Brendel et al.   JAMA Neurology

Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease

(2020) Niklas Mattsson-Carlgren et al.   BRAIN

Defining the Protein Seeds of Neurodegeneration using Real-Time Quaking-Induced Conversion Assays

(2020) Matteo Manca et al.   Biomolecules

Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use

(2020) Cristina d’Abramo et al.   Journal of Personalized Medicine

Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies

(2020) Niklas Mattsson-Carlgren et al.   Nature Communications

Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease

(2020) Shorena Janelidze et al.   JAMA Neurology

Rapid Progress Toward Reliable Blood Tests for Alzheimer Disease

(2020) Elisabeth H. Thijssen et al.   JAMA Neurology

Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene

(2019) Giuseppe Di Fede et al.   Acta Neuropathologica Communications

Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology

(2019) Harald Hampel et al.   Frontiers in Pharmacology

Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes

(2019) Matthew P. Pase et al.   JAMA Neurology

18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes

(2019) Richard M. Tsai et al.   Alzheimers Research & Therapy

Cerebrospinal Fluid and Plasma Biomarkers in Neurodegenerative Diseases

(2019) Yusuke Seino et al.   JOURNAL OF ALZHEIMERS DISEASE

Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism

(2019) Radu Constantinescu et al.   ACTA NEUROLOGICA SCANDINAVICA

Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest

(2019) Martha S Foiani et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cellular and regional vulnerability in frontotemporal tauopathies

(2019) Shelley L. Forrest et al.   ACTA NEUROPATHOLOGICA

Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies

(2019) Heiko Kroth et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A frontline defense against neurodegenerative diseases:the development of early disease detection methods

(2019) Filippo Baldacci et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics

(2019) Anna Jeppsson et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Time for the systems-level integration of aging: Resilience enhancing strategies to prevent Alzheimer’s disease

(2019) Harald Hampel et al.   PROGRESS IN NEUROBIOLOGY

Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status

(2019) Sebastian Palmqvist et al.   JAMA Neurology

Cognitive impairment across ALS clinical stages in a population-based cohort

(2019) Adriano Chiò et al.   NEUROLOGY

4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration

(2019) Eri Saijo et al.   ACTA NEUROPATHOLOGICA

Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948

(2019) Ruben Smith et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Biomarker-guided clustering of Alzheimer's disease clinical syndromes

(2019) Nicola Toschi et al.   NEUROBIOLOGY OF AGING

Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease

(2019) Enrica Cavedo et al.   NEUROLOGY

Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography

(2018) Michelle M. Mielke et al.   Alzheimers & Dementia

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Diagnosis of multiple system atrophy

(2018) Jose-Alberto Palma et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Is longitudinal tau PET ready for use in Alzheimer’s disease clinical trials?

(2018) Oskar Hansson et al.   BRAIN

Longitudinal tau PET in ageing and Alzheimer’s disease

(2018) Clifford R Jack et al.   BRAIN

PET imaging of tau protein targets: a methodology perspective

(2018) Cristina Lois et al.   Brain Imaging and Behavior

Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers

(2018) James P. Quinn et al.   JOURNAL OF ALZHEIMERS DISEASE

Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease

(2018) Che-Chuan Yang et al.   JOURNAL OF ALZHEIMERS DISEASE

Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy

(2018) Tommaso Schirinzi et al.   JOURNAL OF NEURAL TRANSMISSION

[18F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation

(2018) F. Ali et al.   JOURNAL OF NEUROLOGY

First-in-human brain imaging of Alzheimer dementia patients and elderly controls with18F-MK-6240, a PET tracer targeting neurofibrillary tangle pathology

(2018) Talakad G Lohith et al.   JOURNAL OF NUCLEAR MEDICINE

In vivo characterization and quantification of neurofibrillary tau PET radioligand [18F]MK-6240 in humans from Alzheimer’s disease dementia to young controls

(2018) Tobey J Betthauser et al.   JOURNAL OF NUCLEAR MEDICINE

First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948

(2018) Dean F. Wong et al.   JOURNAL OF NUCLEAR MEDICINE

Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer pathology

(2018) J.J. van der Zande et al.   NEUROBIOLOGY OF AGING

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum

(2018) Lieke H.H. Meeter et al.   NEUROLOGY

CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders

(2018) David J. Irwin et al.   NEUROLOGY

Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic

(2018) Ross W. Paterson et al.   Alzheimers Research & Therapy

[18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy

(2018) Matthias Brendel et al.   Frontiers in Aging Neuroscience

α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity

(2018) Simona Daniele et al.   Frontiers in Molecular Neuroscience

PET Imaging of Neuropathology in Tauopathies: Progressive Supranuclear Palsy

(2018) Vladimir Kepe et al.   JOURNAL OF ALZHEIMERS DISEASE

Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis

(2018) Antonio Scarafino et al.   JOURNAL OF NEUROLOGY

Significance of CSF NfL and tau in ALS

(2018) Stefanie Schreiber et al.   JOURNAL OF NEUROLOGY

New classification of tauopathies

(2018) G.U. Höglinger et al.   REVUE NEUROLOGIQUE

Current state of Alzheimer’s fluid biomarkers

(2018) José Luis Molinuevo et al.   ACTA NEUROPATHOLOGICA

Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease

(2018) Zhicheng Chen et al.   Alzheimers & Dementia

Plasma tau/amyloid-β1–42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer’s disease

(2018) Jong-Chan Park et al.   BRAIN

Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study

(2018) Samir Abu-Rumeileh et al.   JOURNAL OF ALZHEIMERS DISEASE

Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

(2018) Harald Hampel et al.   Nature Reviews Neurology

Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease

(2017) Jeffrey S. Phillips et al.   HUMAN BRAIN MAPPING

CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes

(2017) Vasilios C. Constantinides et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Amyotrophic lateral sclerosis

(2017) Michael A van Es et al.   LANCET

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

(2017) David J Irwin et al.   LANCET NEUROLOGY

Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia

(2017) K Chiotis et al.   MOLECULAR PSYCHIATRY

Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study

(2017) Manuel Delgado-Alvarado et al.   MOVEMENT DISORDERS

PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins

(2017) Alexandra Perez-Soriano et al.   MOVEMENT DISORDERS

The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases

(2017) Céline Vermeiren et al.   MOVEMENT DISORDERS

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

(2017) Yvette C Wong et al.   NATURE MEDICINE

A clinicopathological approach to the diagnosis of dementia

(2017) Fanny M. Elahi et al.   Nature Reviews Neurology

CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP

(2017) Julio C. Rojas et al.   NEUROLOGY

Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls

(2017) Brit Mollenhauer et al.   NEUROLOGY

Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria

(2017) Michael J. Strong et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging

(2017) Michelle M. Mielke et al.   JAMA Neurology

Cortical laminar tau deposits and activated astrocytes in Alzheimer’s disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography

(2017) Laetitia Lemoine et al.   Scientific Reports

Multimodal evaluation demonstrates in vivo 18F-AV-1451 uptake in autopsy-confirmed corticobasal degeneration

(2016) Corey T. McMillan et al.   ACTA NEUROPATHOLOGICA

Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort

(2016) Jeffrey L. Dage et al.   Alzheimers & Dementia

In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum

(2016) Hanna Cho et al.   ANNALS OF NEUROLOGY

Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology

(2016) Helen Ling et al.   BRAIN

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease

(2016) Rik Ossenkoppele et al.   BRAIN

Tau imaging with [18F]THK-5351 in progressive supranuclear palsy

(2016) A. Ishiki et al.   EUROPEAN JOURNAL OF NEUROLOGY

Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm

(2016) Konstantinos Chiotis et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies

(2016) Nicolas R. Barthélemy et al.   JOURNAL OF ALZHEIMERS DISEASE

Positron emission tomography imaging of tau pathology in progressive supranuclear palsy

(2016) Sarah Coakeley et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

(2016) Bob Olsson et al.   LANCET NEUROLOGY

[18F]AV-1451 tau positron emission tomography in progressive supranuclear palsy

(2016) Jennifer L. Whitwell et al.   MOVEMENT DISORDERS

Subcortical18F-AV-1451 binding patterns in progressive supranuclear palsy

(2016) Hanna Cho et al.   MOVEMENT DISORDERS

Elevated in vivo [18F]-AV-1451 uptake in a patient with progressive supranuclear palsy

(2016) Jochen Hammes et al.   MOVEMENT DISORDERS

Tau PET in Alzheimer disease and mild cognitive impairment

(2016) Hanna Cho et al.   NEUROLOGY

Plasma tau in Alzheimer disease

(2016) Niklas Mattsson et al.   NEUROLOGY

In vivo visualization of tau deposits in corticobasal syndrome by 18 F-THK5351 PET

(2016) Akio Kikuchi et al.   NEUROLOGY

PET Imaging of Tau Deposition in the Aging Human Brain

(2016) Michael Schöll et al.   NEURON

Tau Imaging in Alzheimer’s Disease Diagnosis and Clinical Trials

(2016) Jared R. Brosch et al.   Neurotherapeutics

Tauopathies as clinicopathological entities

(2016) David J. Irwin   PARKINSONISM & RELATED DISORDERS

An autoradiographic evaluation of AV-1451 Tau PET in dementia

(2016) Val J. Lowe et al.   Acta Neuropathologica Communications

Motor function and behaviour across the ALS-FTD spectrum

(2015) D. De Silva et al.   ACTA NEUROLOGICA SCANDINAVICA

Tau positron emission tomographic imaging in aging and early Alzheimer disease

(2015) Keith A. Johnson et al.   ANNALS OF NEUROLOGY

Pathological Interface Between Oligomeric Alpha-Synuclein and Tau in Synucleinopathies

(2015) Urmi Sengupta et al.   BIOLOGICAL PSYCHIATRY

Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Patients with Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis with the C9ORF72 Repeat Expansion

(2015) Anna K�m�l�inen et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

(2015) N K Magdalinou et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis

(2015) Carlo Wilke et al.   NEUROBIOLOGY OF AGING

Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative

(2015) Brice Laurens et al.   NEUROBIOLOGY OF DISEASE

Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson’s disease

(2015) Xuemei Wang et al.   NEUROSCIENCE LETTERS

Multiple-System Atrophy

(2015) Alessandra Fanciulli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer’s Disease Using [18F]THK-5117 Positron Emission Tomography

(2015) Aiko Ishiki et al.   PLoS One

In vivo tau imaging: Obstacles and progress

(2014) Victor L. Villemagne et al.   Alzheimers & Dementia

Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy

(2014) Rik Ossenkoppele et al.   ANNALS OF NEUROLOGY

Divergent CSF   alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy

(2014) D. Wagshal et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials

(2014) Reisa Sperling et al.   NEURON

Biomarkers in biological fluids for dementia with Lewy bodies

(2014) Sebastian Schade et al.   Alzheimers Research & Therapy

Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia

(2014) Barbara Borroni et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid

(2013) Heiko Braak et al.   ACTA NEUROPATHOLOGICA

[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

(2013) Chun-Fang Xia et al.   Alzheimers & Dementia

Tau pathology and neurodegeneration

(2013) Maria Grazia Spillantini et al.   LANCET NEUROLOGY

Criteria for the diagnosis of corticobasal degeneration

(2013) M. J. Armstrong et al.   NEUROLOGY

Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls

(2013) Masahiro Maruyama et al.   NEURON

CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls

(2013) Megan K. Herbert et al.   PARKINSONISM & RELATED DISORDERS

Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

(2012) Sara Hall et al.   ARCHIVES OF NEUROLOGY

Translational biomarker discovery in clinical metabolomics: an introductory tutorial

(2012) Jianguo Xia et al.   Metabolomics

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Clifford R. Jack et al.   Alzheimers & Dementia

Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome

(2011) Naomi Kouri et al.   BRAIN

Motor Neuron dysfunction in frontotemporal dementia

(2011) James R. Burrell et al.   BRAIN

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

(2011) Heiko Braak et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy

(2011) H. B. Kuiperij et al.   NEUROLOGY

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

(2011) N. S. M. Schoonenboom et al.   NEUROLOGY

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes

(2011) Sara Bech et al.   PARKINSONISM & RELATED DISORDERS

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

(2010) Min Shi et al.   ANNALS OF NEUROLOGY

The Epidemiology of Dementia Associated with Parkinson's Disease

(2010) Dag Aarsland et al.   BRAIN PATHOLOGY

Immunomagnetic reduction assay using high-Tc superconducting-quantum-interference-device-based magnetosusceptometry

(2010) J. J. Chieh et al.   JOURNAL OF APPLIED PHYSICS

Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome

(2010) M.B. Aerts et al.   MOVEMENT DISORDERS

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologies

(2009) Paul W. Thompson et al.   JOURNAL OF NEUROCHEMISTRY

Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies

(2008) Lucilla Parnetti et al.   BIOLOGICAL PSYCHIATRY

Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood

(2008) Robin Barbour et al.   Neurodegenerative Diseases

Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy

(2008) B. Borroni et al.   NEUROLOGY

Pattern of Tau forms in CSF is altered in progressive supranuclear palsy

(2007) B. Borroni et al.   NEUROBIOLOGY OF AGING